CellaVision

CellaVision CLVSF Stock

$20.83   0.000000%
Add to favorites
Market Cap
$496.83M
LOW - HIGH [24H]
$20.83 - $20.83
VOLUME [24H]
$100.00
P/E Ratio
33.59
Earnings per share
$0.62
ISIN
SE0000683484
Price   Prediction

CellaVision Price Chart

Sorry, that's all we've gotfor now...

CellaVision (CLVSF) stock price today is 20.83 USD on OTC Markets OTCPK (0% on the day). Updated .

CellaVision CLVSF Financial and Trading Overview

CellaVision stock price 20.83 USD
Previous Close 20.83 USD
Open 20.83 USD
Bid 19.53 USD x 10000
Ask 20.38 USD x 10000
Day's Range 20.83 - 20.83 USD
52 Week Range 13.49 - 20.83 USD
Volume 100 USD
Avg. Volume 1 USD
Market Cap 496.83M USD
Beta (5Y Monthly) 0.866
PE Ratio (TTM) 33.596775
EPS (TTM) 0.62 USD
Forward Dividend & Yield 0.3 (1.42%)
Ex-Dividend Date April 29, 2026
1y Target Est N/A

CLVSF Valuation Measures

Enterprise Value N/A
Trailing P/E 33.596775
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 0.5834734
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

CellaVision Stock Price History

Beta (5Y Monthly) 0.866
52-Week Change 23.79%
S&P500 52-Week Change 10.51%
52 Week High 20.83 USD
52 Week Low 13.49 USD
50-Day Moving Average 15.23 USD
200-Day Moving Average 14.74 USD

CLVSF Share Statistics

Avg. Volume (3 month) 1 USD
Avg. Daily Volume (10-Days) 10 USD
Shares Outstanding 23.85M
Float 19.5M
Short Ratio N/A
% Held by Insiders 18.94%
% Held by Institutions 71.10%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0.475
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 18.07%
Operating Margin (ttm) 0%
Gross Margin 68.01%
EBITDA Margin 26.01%

Management Effectiveness

Return on Assets (ttm) 9.65%
Return on Equity (ttm) 15.45%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 13.60%
Gross Profit (ttm) N/A
EBITDA 198.5M USD
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) 0.62
Quarterly Earnings Growth (yoy) 28.19%

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 5.34 USD
Current Ratio (mrq) 3.485
Book Value Per Share (mrq) 35.7

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) 103.06M USD

Profile of CellaVision

Country United States
State N/A
City Lund
Address MobilvAegen 12
ZIP 223 62
Phone 46 4 64 60 16 00
Website https://www.cellavision.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 252

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides analyzers for microscopy systems; and DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Bone Marrow Aspirate Application enables laboratories to automate, standardize, and simplify morphological examination of bone marrow aspirate samples; CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas, a library of blood cell images and descriptions created by digital cell morphology experts; CellaVision Review Software removes restrictive constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.

Q&A For CellaVision Stock

What is a current CLVSF stock price?

CellaVision CLVSF stock price today per share is 20.83 USD.

How to purchase CellaVision stock?

You can buy CLVSF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CellaVision?

The stock symbol or ticker of CellaVision is CLVSF.

Which industry does the CellaVision company belong to?

The CellaVision industry is Medical Devices.

How many shares does CellaVision have in circulation?

The max supply of CellaVision shares is 23.85M.

What is CellaVision Price to Earnings Ratio (PE Ratio)?

CellaVision PE Ratio is 33.59677500 now.

What was CellaVision earnings per share over the trailing 12 months (TTM)?

CellaVision EPS is 0.62 USD over the trailing 12 months.

Which sector does the CellaVision company belong to?

The CellaVision sector is Healthcare.

$2.17T
Total marketcap
$70.24B
Total volume
BTC 58.10%   •   ETH 9.84%
Dominance
Select currency